Quince Therapeutics, Inc. (QNCX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

16

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
14-Dec-23 6:21 PM View:	14-Dec-23 Purchase $23.53K	Lamond David Director		Quince Therapeutics, Inc. - QNCX	59% 4.22M to 6.69M	0	0	--	--	Show Txns Hide Txns

22-Aug-24 5:51 PM View:	20-Aug-24 Private Purchase $31.45K	Ryan Charles S. President		Quince Therapeutics, Inc. - QNCX	65% 74.07K to 122.46K	0	0	--	--	Show Txns Hide Txns

21-Aug-24 6:38 PM View:	21-Aug-24 Purchase $19.34K	Hannah Brendan Chief Business Officer and COO		Quince Therapeutics, Inc. - QNCX	47% 201.56K to 296.54K	0	0	--	--	Show Txns Hide Txns

03-Sep-24 5:38 PM View:	30-Aug-24 Purchase $53.90K	Thye Dirk CEO AND CHIEF MEDICAL OFFICER Director		Quince Therapeutics, Inc. - QNCX	88% 448.91K to 843.94K	0	0	--	--	Show Txns Hide Txns